*Study:
A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)
Activity Counseling Trial (ACT)
Acute Respiratory Distress Network Studies 01 and 03 (ARDSNet 01 and 03) Lower versus higher tidal volume, ketoconazole treatment and lisofylline treatment (ARMA/KARMA/LARMA)
Acute Respiratory Distress Network Study 02 (ARDSNet 02) Late Steroid Rescue Study (LaSRS)
Acute Respiratory Distress Network Study 04 (ARDSNet 04) Assessment of Low tidal Volume and elevated End-expiratory volume to Obviate Lung Injury (ALVEOLI)
Acute Respiratory Distress Network Study 05 (ARDSNet 05) Fluid and Catheter Treatment Trial (FACTT)
Alpha1-Antitrypsin Deficiency Registry (AADR)
Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission: Pediatric AIDS Clinical Trials Group (PACTG) protocol 185
Antiarrhythmics Versus Implantable Defibrillators (AVID)
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Aspirin-Myocardial Infarction Study (AMIS)
Asthma Clinical Research Network (ACRN) Beta Adrenergic Response by Genotype (BARGE)
Asthma Clinical Research Network (ACRN) Beta Agonist in Mild Asthma Study (BAGS)
Asthma Clinical Research Network (ACRN) Colchicine In Moderate Asthma (CIMA)
Asthma Clinical Research Network (ACRN) Dose of Inhaled Corticosteroids with Equisystemic Effects (DICE)
Asthma Clinical Research Network (ACRN) Measuring Inhaled Corticosteroid Efficacy (MICE)
Asthma Clinical Research Network (ACRN) Salmeterol Off CorticoSteroids (SOCS) and Salmeterol Inhaled Corticosteroids (SLIC)
Asthma Clinical Research Network (ACRN) IMProving Asthma Control Trial (IMPACT)
Asthma Clinical Research Network (ACRN) Predicting Response to Inhaled Corticosteroid Efficacy (PRICE)
Asthma Clinical Research Network (ACRN) Salmeterol and Leukotriene Modifiers vs. Salmeterol and ICS Treatment (SLiMSIT)
Asthma Clinical Research Network (ACRN) Smoking Modulates Outcomes of Glucocorticoid Therapy in Asthma (SMOG)
Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT) and Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
Atherosclerosis Risk in Communities Study (ARIC)
Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM)
Beta-Blocker Evaluation in Survival Trial (BEST)
Beta-Blocker Heart Attack Trial (BHAT)
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants (BMT CTN 0101)
Bogalusa Heart Study (BHS)
Bypass Angioplasty Revascularization Investigation (BARI)
Cardiac Arrhythmia Suppression Trial (CAST)
Cardiovascular Health Study (CHS)
Childhood Asthma Management Program (CAMP)
Clinical Study of Intermittent Positive Pressure Breathing (IPPB)
Cooperative Study of Sickle Cell Disease (CSSCD)
Cord Blood Transplantation Study (COBLT)
Coronary Artery Risk Development in Young Adults (CARDIA)
Coronary Artery Surgery Study (CASS)
Dietary Approaches to Stop Hypertension (DASH)
Dietary Approaches to Stop Hypertension - Sodium Study (DASH-Sodium)
Dietary Intervention Study in Children (DISC)
Digitalis Investigation Group (DIG)
Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD)
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE)
Framingham Heart Study-Cohort
Framingham Heart Study-Offspring
Framingham Heart Study-Third Generation Cohort (Gen III)
General Serum Repository and General Leukocyte/Plasma Repository (GSR/GLPR)
Hemochromatosis and Iron Overload Screening Study (HEIRS)
High Frequency Ventilation in Premature Infants (HIFI)
Honolulu Heart Program (HHP)
Human Herpes Virus 8 Special Collection from the General Leukocyte/Plasma Repository (HHV8/GLPR)
Hypertension Detection and Follow-Up Program (HDFP)
Lipid Research Clinics (LRC) Coronary Primary Prevention Trial (CPPT)
Lipid Research Clinics (LRC) Prevalence Study (PS)
Lung Health Study (LHS)
Magnesium in Coronaries (MAGIC)
Multi-Ethnic Study of Atherosclerosis (MESA)
Multicenter Hemophilia Cohort Studies (MHCS-I and MHCS-II)
Multicenter Study of Hydroxyurea (MSH)
Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)
NHLBI Growth and Health Study (NGHS)
NHLBI Umbilical Cord Blood Unit Collection
National Emphysema Treatment Trial (NETT)
National Longitudinal Mortality Study (NLMS)
Natural History Study of Non-A, Non-B Post-Transfusion Hepatitis (NANB-TAH)
New Data Analysis Methods for Actigraphy in Sleep Medicine (MASM)
Novel Influenza A Surveillance Registry (H1N1)
Occluded Artery Trial (OAT)
Optimal Macronutrient Intake Trial to Prevent Heart Disease (OMNI Heart)
Other
PREMIER: Lifestyle Interventions for Blood Pressure Control
Patient Registry for Primary Pulmonary Hypertension (PPH Registry)
Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)
Post Coronary Artery Bypass Graft (CABG) Study
Prevention and Treatment of Hypertension Study (PATHS)
Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)
Psychophysiological Investigation of Myocardial Ischemia (PIMI)
Public Access Defibrillation (PAD) Community Trial
Puerto Rico Heart Health Program (PRHHP)
Pulmonary Complications of HIV Infection Study (PACS)
REDS Allogeneic Donor and Recipient Repository (RADAR)
REDS-II Donation and Deferral Database (CORE)
Rapid Early Action for Coronary Treatment (REACT)
Raynaud's Treatment Study (RTS)
Retrovirus Epidemiology Donor Study (REDS) HTLV Cohort
Retrovirus Epidemiology Donor Study (REDS): Special Repository (SR) Collections
Retrovirus Epidemiology Donor Study - II (REDS-II) Molecular Surveillance (MS)
Retrovirus Epidemiology Donor Study-II (Reds-II) Donor Iron Status Evaluation Study (RISE)
Retrovirus Epidemiology Donor Study-II (Reds-II) Leukocyte Antibodies Prevalence Study (LAPS)
Studies of Left Ventricular Dysfunction (SOLVD)
Systolic Hypertension in the Elderly Program (SHEP)
T-Cell Depletion in Unrelated Donor Marrow Transplantation (TCD)
The Jackson Heart Study (JHS)
Thrombolysis in Myocardial Ischemia Trial (TIMI II)
Thrombolysis in Myocardial Ischemia Trial (TIMI III)
Transfusion Safety Study (TSS)
Transfusion-Transmitted Viruses Study (TTVS)
Trial of Activity for Adolescent Girls (TAAG)
Trial to Reduce Alloimmunization to Platelets (TRAP)
Trials of Hypertension Prevention (TOHP)
Viral Activation Transfusion Study (VATS)
Weight Loss Maintenance (WLM)
Women's Angiographic Vitamin and Estrogen Trial (WAVE)
Women's Health Initiative Study (WHI-OS)
Women's Health Initiative: Clinical Trials (WHI-CT)
Women's Ischemia Syndrome Evaluation (WISE)
Hold down "Control", or "Command" on a Mac, to select more than one.
*Number of Specimens: Approximate count of specimens required for your study. *Material type:
*Minimum volume (or mass if requesting DNA): Please include units.
*Optimum volume (or mass if requesting DNA): Please include units.
Specimen requirements: Describe any additional requirements pertaining to the biospecimens themselves, such as anticoagulant used, additives, preservatives, etc.
Subject characteristics: Describe the characteristics of the subjects to be searched for available specimens. Criteria might include gender, age, disease status, genotype, etc. Be as specific as possible.
*Describe this request, including a summary of the rationale, main hypothesis and proposed research aims: A brief overview of your research needs.
*Is this a pre-application search for NHLBI RFA-HL-12-004?
Scientific background and rationale: Provide the research protocol background, objectives and hypothesis.
*Analyte(s) or parameter(s) to be tested: Describe the assay(s) to be performed and include any test volume requirements.
*Type of assay(s)/ platform(s) to be used: Describe the assay kit(s)/platform(s) to be used, if applicable.
*Rationale for number of biospecimens requested, including power calculations, and describe the use of covariates, if applicable: Also describe your intended use of covariates from study datasets, if applicable.
*Will the results be used for a commercial purpose? A "Yes" response defines this as a "Commercial Purpose" request.
*Original Study Investigator? Were you an investigator with the original (parent) study(ies) referenced in this request?
*Information Security: Please check the information security practices to be used: Study data must be maintained in a secure and controlled environment
Comments: